| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 99 | 60 | 68 | 31 | 85 | 71 | 86 | 62 | 87 | 68 | 98 | 80 | 130 | 66 | 115 | 123 | 140 | 78 | 142 | 129 | 186 | 113 | 157 | 119 | 174 | 130 | 104 | 175 | 279 | 187 | 204 | 121 | 130 | 145 | 112 | 52 | 156 | 70 | 101 | 96 | 120 | 92 | 75 | 126 | 161 |
| Expenses | 91 | 47 | 62 | 39 | 69 | 59 | 64 | 53 | 76 | 60 | 81 | 61 | 97 | 56 | 89 | 98 | 111 | 71 | 125 | 104 | 138 | 84 | 126 | 100 | 134 | 104 | 82 | 131 | 207 | 159 | 167 | 105 | 122 | 140 | 114 | 69 | 141 | 116 | 118 | 100 | 114 | 102 | 80 | 123 | 150 |
| EBITDA | 8 | 12 | 6 | -8 | 16 | 12 | 22 | 10 | 11 | 9 | 16 | 19 | 33 | 9 | 25 | 24 | 29 | 7 | 17 | 25 | 48 | 30 | 31 | 19 | 40 | 26 | 22 | 45 | 72 | 28 | 37 | 16 | 8 | 5 | -2 | -17 | 15 | -45 | -18 | -4 | 6 | -11 | -6 | 3 | 12 |
| Operating Profit % | 2 % | 20 % | 7 % | -26 % | 12 % | 16 % | 25 % | 14 % | 12 % | 9 % | 15 % | 18 % | 24 % | 13 % | 21 % | 18 % | 17 % | 8 % | 11 % | 17 % | 24 % | 25 % | 19 % | 13 % | 22 % | 19 % | 21 % | 25 % | 24 % | 14 % | 17 % | 10 % | 4 % | 2 % | -3 % | -36 % | 8 % | -67 % | -20 % | -6 % | 5 % | -12 % | -9 % | 2 % | 6 % |
| Depreciation | 1 | 3 | 3 | 2 | 3 | 3 | 4 | 2 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 9 | 11 | 9 | 8 | 9 | 8 | 9 | 9 | 9 | 9 | 9 | 12 | 11 | 12 | 12 | 10 | 11 | 12 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 3 | 4 | 4 | 3 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 3 | 3 | 4 | 5 | 6 | 6 | 7 | 6 | 6 | 7 | 7 | 9 | 10 | 10 | 11 | 8 | 7 | 8 |
| Profit Before Tax | 4 | 7 | 2 | -11 | 15 | 5 | 15 | 5 | 4 | 6 | 10 | 13 | 27 | 3 | 18 | 15 | 20 | -2 | 8 | 16 | 40 | 22 | 24 | 11 | 32 | 17 | 12 | 33 | 58 | 15 | 25 | 1 | -6 | -11 | -18 | -32 | -1 | -62 | -39 | -25 | -16 | -33 | -24 | -16 | -8 |
| Tax | 1 | 2 | -0 | -3 | 9 | 1 | 4 | 4 | 1 | 2 | 3 | 6 | 10 | 1 | 6 | 5 | 8 | -1 | 3 | 3 | 9 | 6 | 6 | 4 | 8 | 5 | 3 | 9 | 15 | 4 | 6 | 0 | -1 | -3 | -4 | -8 | 0 | -22 | 0 | 15 | 0 | 0 | 0 | 0 | -0 |
| Net Profit | 3 | 5 | 2 | -8 | 6 | 4 | 11 | 1 | 4 | 4 | 7 | 7 | 17 | 2 | 12 | 10 | 13 | -1 | 5 | 12 | 31 | 16 | 18 | 7 | 24 | 13 | 9 | 25 | 43 | 11 | 18 | 1 | -5 | -8 | -13 | -24 | -1 | -40 | -39 | -40 | -16 | -33 | -24 | -16 | -8 |
| EPS in ₹ | 1.74 | 2.66 | 1.05 | -4.03 | 2.88 | 1.93 | 5.74 | 0.36 | 1.77 | 2.04 | 3.44 | 3.67 | 8.78 | 0.08 | 5.92 | 5.10 | 6.50 | -0.57 | 2.70 | 6.22 | 15.94 | 8.27 | 9.12 | 3.61 | 12.24 | 6.63 | 4.63 | 12.63 | 21.97 | 5.82 | 9.34 | 0.43 | -2.54 | -4.18 | -6.85 | -12.41 | -0.50 | -20.26 | -19.66 | -20.59 | -8.20 | -16.85 | -11.35 | -7.04 | -3.48 |
Astec Lifesciences
Astec Lifesciences
717.20
-9.55
(-1.31%)
Market Cap
1,598.08 Cr
PE Ratio
-20.04
Volume
16,169.00
Day High - Low
735.50 - 715.65
52W High-Low
990.82 - 513.40
Q3 Quarterly Results are out. Check out the updated financials9 hrs ago
Show All
Key Fundamentals
Market Cap
1,598.08 Cr
EPS
-37.79
PE Ratio
-20.04
PB Ratio
4.15
Book Value
175.30
EBITDA
-6.62
Dividend Yield
0.00 %
Industry
Chemicals Sector
Pesticides & Agrochemicals Return on Equity
-57.32
Debt to Equity
1.74
Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
Astec LifeSciences reported total income of ₹45,321.65 crore for FY26, up from ₹38,693.22 crore in FY25. The company posted a net loss of ₹8,087.62 crore for the year ended March 31, 2026.
ASTEC LifeSciences Board Restructures Leadership
Apr 13, 2026
Apr 13, 2026ASTEC LifeSciences announces major board changes with Nadir Godrej retiring as Chairman, Vishal Sharma appointed as new Chairman, and Burjis N. Godrej transitioning from Managing Director to Non-Executive Director.
Astec LifeSciences Limited submits compliance certificate under SEBI Depositories Regulations for quarter ended March 31, 2026, confirming no securities received for dematerialization.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
645.70 | #1 54,508.01 | 27.17 | #1 47,123.00 | 8.13 | 820 | -42.56 | 51.95 | |
3,170.00 | 48,094.64 | 32.41 | 8,322.00 | 5.70 | #1 1,660 | -16.47 | 58.73 | |
434.60 | 21,692.87 | 40.60 | 3,268.60 | 11.19 | 506 | -13.27 | 56.36 | |
4,676.30 | 21,016.27 | 30.93 | 5,593.10 | 7.89 | 568 | 179.82 | 42.05 | |
1,154.85 | 10,419.11 | 18.55 | 4,379.40 | #1 35.89 | 304 | #1 366.56 | 64.31 | |
267.93 | 5,210.40 | 31.33 | 2,631.40 | 6.54 | 164 | -274.07 | 54.80 | |
1,064.80 | 4,799.94 | #1 16.16 | 2,071.30 | 15.49 | 297 | 27.97 | 61.08 | |
160.18 | 3,748.43 | -82.74 | 1,242.60 | -30.48 | -92 | 71.82 | 52.90 | |
267.90 | 3,473.83 | 263.53 | 449.80 | 9.63 | 14 | 27.78 | 70.75 | |
1,394.80 | 2,318.31 | 17.40 | 1,199.00 | 12.53 | 141 | -1.23 | 43.18 |
Growth Rate
Revenue Growth
15.83 %
Net Income Growth
-39.84 %
Cash Flow Change
-182.19 %
ROE
351.69 %
ROCE
219.94 %
EBITDA Margin (Avg.)
-90.68 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 362 | 330 | 334 | 413 | 461 | 572 | 678 | 897 | 979 | 975 | 881 | 942 |
| Fixed Assets | 133 | 95 | 103 | 115 | 167 | 194 | 213 | 340 | 319 | 386 | 499 | 479 |
| Current Assets | 204 | 191 | 198 | 232 | 249 | 332 | 330 | 516 | 499 | 399 | 341 | 443 |
| Capital Work in Progress | 12 | 20 | 8 | 42 | 19 | 24 | 116 | 23 | 127 | 165 | 21 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 138 |
| Other Assets | 217 | 215 | 223 | 256 | 275 | 354 | 349 | 534 | 534 | 424 | 361 | 0 |
| Total Equity & Liabilities | 362 | 330 | 334 | 413 | 461 | 572 | 678 | 897 | 979 | 975 | 881 | 942 |
| Current Liabilities | 178 | 203 | 194 | 238 | 249 | 318 | 322 | 491 | 526 | 397 | 366 | 500 |
| Non Current Liabilities | 49 | 9 | 2 | 5 | 10 | 7 | 46 | 10 | 34 | 208 | 281 | 51 |
| Total Equity | 135 | 118 | 138 | 170 | 203 | 247 | 309 | 397 | 420 | 370 | 235 | 391 |
| Reserve & Surplus | 116 | 99 | 119 | 150 | 183 | 227 | 290 | 377 | 400 | 350 | 215 | 368 |
| Share Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 22 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -0 | 2 | 1 | -3 | -0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Investing Activities | -19 | -17 | -18 | -49 | -53 | -74 | -73 | -104 | -113 | -135 | -15 |
| Operating Activities | 8 | -13 | 19 | 65 | 15 | 168 | -8 | 24 | 75 | 10 | -8 |
| Financing Activities | 12 | 31 | -1 | -18 | 37 | -95 | 81 | 81 | 38 | 125 | 24 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 65.23 % | 65.20 % | 65.20 % | 65.19 % | 65.29 % | 65.29 % | 66.77 % | 66.77 % | 66.77 % | 66.76 % | 66.75 % | 66.75 % | 66.75 % | 66.75 % | 66.75 % | 66.75 % | 70.87 % | 70.87 % | 72.42 % | 72.42 % | 71.97 % | 71.97 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.28 % | 1.25 % | 1.03 % | 0.53 % | 1.20 % | 0.25 % | 0.02 % | 0.02 % | 0.00 % | 0.04 % | 0.02 % |
| DIIs | 9.76 % | 9.58 % | 11.36 % | 11.69 % | 11.16 % | 10.24 % | 9.83 % | 9.56 % | 9.58 % | 10.15 % | 9.15 % | 9.74 % | 7.88 % | 3.38 % | 4.51 % | 5.41 % | 4.34 % | 4.26 % | 4.01 % | 4.01 % | 3.17 % | 3.34 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.06 % | 19.33 % | 18.06 % | 17.41 % | 17.46 % | 18.26 % | 18.02 % | 17.86 % | 16.81 % | 17.75 % | 17.91 % | 18.19 % | 19.62 % | 22.52 % | 21.95 % | 20.71 % | 19.62 % | 19.98 % | 18.96 % | 19.32 % | 20.87 % | 20.81 % |
| Others | 5.94 % | 5.89 % | 5.38 % | 5.71 % | 6.09 % | 6.21 % | 5.38 % | 5.82 % | 6.85 % | 5.34 % | 6.19 % | 4.03 % | 4.49 % | 6.33 % | 6.26 % | 5.93 % | 4.91 % | 4.87 % | 4.59 % | 4.25 % | 3.95 % | 3.86 % |
| No of Share Holders | 0 | 19,872 | 22,817 | 21,073 | 19,002 | 16,951 | 17,433 | 17,632 | 17,809 | 18,703 | 18,722 | 19,244 | 19,848 | 19,955 | 19,727 | 19,057 | 18,689 | 18,549 | 18,889 | 18,276 | 22,293 | 21,041 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 1.5 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.26 | 0.28 | 0.39 | 0.15 | 0.09 | 0.11 | 0.14 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 24 Jul 2021 |  Dividend | ₹ 1.50 /share | 22 Jul 2021 | 1,153.34 | 1,373.99 |
| 21 Jul 2022 | Dividend | ₹ 1.50 /share | 19 Jul 2022 | 1,815.32 | 2,053.13 |
| 22 Jul 2023 | Dividend | ₹ 1.50 /share | 21 Jul 2023 | 1,320.32 | 1,281.21 |
| 27 Jul 2023 |  Annual General Meeting | NA | 27 Jul 2023 | 1,320.32 | 1,238.53 |
| 29 Jul 2024 | Annual General Meeting | NA | 29 Jul 2024 | 1,274.65 | 1,273.21 |
| 25 Oct 2024 |  Quarterly Result Announcement | NA | 25 Oct 2024 | 1,088.08 | 1,064.11 |
| 27 Jan 2025 | Quarterly Result Announcement | NA | 27 Jan 2025 | 1,008.69 | 955.39 |
| 23 Apr 2025 | Quarterly Result Announcement | NA | 23 Apr 2025 | 699.75 | 757.08 |
| 04 Jul 2025 |  Rights | 1:7 | 04 Jul 2025 | 929.44 | 940.36 |
| 28 Jul 2025 | Annual General Meeting | NA | 28 Jul 2025 | 757.08 | 900.15 |
| 28 Jul 2025 | Quarterly Result Announcement | NA | 28 Jul 2025 | 897.60 | 900.15 |
| 29 Oct 2025 | Quarterly Result Announcement | NA | 29 Oct 2025 | 748.10 | 683.85 |
| 30 Jan 2026 | Quarterly Result Announcement | NA | 30 Jan 2026 | 660.85 | 575.40 |
| 27 Apr 2026 | Quarterly Result Announcement | NA | 27 Apr 2026 | 749.40 | 722.50 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication14 hrs ago
14 hrs ago32Nd AGM1 day ago
1 day agoBook Closure For 32Nd Annual General Meeting1 day ago
1 day agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release1 day ago
1 day agoFinancial Result1 day ago
1 day agoBoard Meeting Outcome for Outcome Of Board Meeting1 day ago
1 day agoClarification To BSE Regarding Price Movement8 days ago
8 days agoBoard Meeting Intimation for Approval Of Financial ResultsApr 17, 2026
Apr 17, 2026Clarification sought from Astec Lifesciences LtdApr 17, 2026
Apr 17, 2026Announcement under Regulation 30 (LODR)-Change in ManagementApr 13, 2026
Apr 13, 2026Board Meeting Outcome for Outcome Of Board MeetingApr 13, 2026
Apr 13, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Apr 10, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Payment Of Interest On Non-Convertible DebenturesMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Credit RatingMar 25, 2026
Mar 25, 2026Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations) - Disinvestment Of Equity Shares Held In Clean Max Andes Private LimitedMar 09, 2026
Mar 09, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSFeb 24, 2026
Feb 24, 2026Reply On Significant Increase In The Volume Of SecurityFeb 06, 2026
Feb 06, 2026Clarification sought from Astec Lifesciences LtdFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 31, 2026
Jan 31, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 30, 2026
Jan 30, 2026Appointment Of Chief Financial OfficerJan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jan 30, 2026
Jan 30, 2026Outcome Of Board MeetingJan 30, 2026
Jan 30, 2026Board Meeting Outcome for Outcome Of Board MeetingJan 30, 2026
Jan 30, 2026Board Meeting Intimation for Board Meeting Intimation For Approving The Standalone And
Consolidated Unaudited Financial Results For The Quarter And Nine Months Period Ended 31St December 2025 After These Results Are Reviewed By The Audit Committee.Jan 20, 2026
Jan 20, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2026
Jan 13, 2026Closure of Trading WindowDec 24, 2025
Dec 24, 2025Intimation Of Appointment Of Senior Management PersonnelDec 15, 2025
Dec 15, 2025Disclosure Of Voting Results Of Postal Ballot Pursuant To Regulation 44 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateNov 07, 2025
Nov 07, 2025Disclosure Pursuant To Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 07, 2025
Nov 07, 2025Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotNov 07, 2025
Nov 07, 2025 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportNov 07, 2025
Nov 07, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 30, 2025
Oct 30, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportOct 29, 2025
Oct 29, 2025Statement Of Deviation And Variation For The Quarter And Half- Year Ended September 30 2025Oct 29, 2025
Oct 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 29, 2025
Oct 29, 2025Financial Result For The Quarter And Half-Year Ended September 30 2025.Oct 29, 2025
Oct 29, 2025Board Meeting Outcome for Revised OutcomeOct 29, 2025
Oct 29, 2025Financial Result For The Quarter And Half-Year Ended September 30 2025.Oct 29, 2025
Oct 29, 2025Board Meeting Outcome for Outcome Of Board MeetingOct 29, 2025
Oct 29, 2025Change In Senior Management PersonnelOct 24, 2025
Oct 24, 2025Board Meeting Intimation for Board Meeting Intimation For Approving The Standalone And
Consolidated Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 After These Results Are Reviewed By The Audit CommitteeOct 14, 2025
Oct 14, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 09, 2025
Oct 09, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 07, 2025
Oct 07, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 06, 2025
Oct 06, 2025IntimationOct 03, 2025
Oct 03, 2025Intimation For Seeking Shareholders Approval For Material Related Party TransactionsOct 03, 2025
Oct 03, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotOct 03, 2025
Oct 03, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Motilal Oswal BSE 1000 Index Fund Direct-Growth | 0.00% | 1 | 0.00% | 0.00% | |
 ICICI Prudential Commodities Fund Direct-Growth | 0.21% | 0 | 0.00% | -0.01% | |
ICICI Prudential Midcap Direct Plan-Growth | 0.01% | 0 | 0.00% | 0.00% | |
ICICI Prudential Retirement Fund - Hybrid Aggressive Plan Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
 Nippon India Small Cap Fund Direct-Growth | 0.05% | 0 | 0.00% | 0.00% | |
 Tata Retirement Savings Fund Conservative Plan Direct-Growth | 0.00% | 0 | 0.00% | 0.00% | |
Tata Retirement Savings Fund Progressive Plan Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 60.45
ATR(14)
Less Volatile 40.27
STOCH(9,6)
Neutral 75.36
STOCH RSI(14)
Neutral 72.53
MACD(12,26)
Bullish 10.65
ADX(14)
Strong Trend 33.83
UO(9)
Bearish 49.08
ROC(12)
Uptrend And Accelerating 29.78
WillR(14)
Overbought -19.03
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
